Atlas Trials

Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.

Clinical trial NCT03164473 · COMPLETED

Trial details

NCT number
NCT03164473
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Eosinophilic Granulomatosis With Polyangiitis
Start date
2018-03-07
Primary completion
2024-09-23
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.